Related Experiment Video
Updated: May 3, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
17.7K
Dendritic cell-based immunotherapy in ovarian cancer
An Coosemans1, Ignace Vergote1, Stefaan W Van Gool2
1Department of Gynecologic Oncology; Leuven Cancer Institute, KU Leuven, Belgium.
Oncoimmunology
|February 7, 2014
Summary
New dendritic cell vaccines offer hope for treating aggressive ovarian cancer, a disease with a high mortality rate. This research outlines an optimal immunotherapeutic strategy for this gynecological malignancy.
Area of Science:
- Immunotherapy
- Oncology
- Vaccinology
Background:
- Ovarian cancer is an aggressive gynecological malignancy with an 80% mortality rate worldwide.
- There is an urgent need for novel and effective treatments for ovarian cancer.
- Dendritic cell-based vaccines are an emerging immunotherapeutic approach with significant potential.
Purpose of the Study:
- To propose an optimal dendritic cell-based immunotherapeutic strategy for ovarian cancer.
- To highlight the promise of dendritic cell vaccines in combating gynecological malignancies.
Main Methods:
- Review and synthesis of current research on dendritic cell vaccines and ovarian cancer.
- Conceptualization of an integrated immunotherapeutic approach.
Main Results:
- Dendritic cell-based immunotherapy presents a promising avenue for ovarian cancer treatment.
- An optimized strategy could significantly improve patient outcomes.
Conclusions:
- Dendritic cell-based vaccines hold considerable promise for managing ovarian cancer.
- Further development and clinical investigation of these strategies are warranted.
Related Concept Videos
01:27Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
01:27Cytotoxic T Cells-mediated Immune Response
7.0K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.0K